AstraZeneca, Torrent Settle Time-Release Seroquel IP Row
As part of the consent judgment, Torrent admitted AstraZeneca’s patent on the anti-depressant is enforceable and valid, and agreed not to produce a generic version of Seroquel XR until November 2016.
Representatives for the parties did not immediately respond to requests for comment Friday.
AstraZeneca filed suit...
Already a subscriber? Click here to login